CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
No Intervention Providedother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03971578
NCT03971578N/ACompleted
CompareCT.gov

Screening Device for Autism Spectrum Disorders Using High Stimulation Rate ABR With Continuous Loop Averaging Deconvolution

Intelligent Hearing Systems·observational·Posted Jun 3, 2019·Updated Aug 14, 2023

In Brief

An observational study evaluating No Intervention Provided for Autism Spectrum Disorder. Completed, enrolled 81 participants across 1 site.

Detailed Summary

The purpose of this study is to develop an Auditory Brainstem Response (ABR) based neurological screening method to detect increased risk for Autism Spectrum Disorders (ASD) and other neurological conditions in newborns.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder
CountriesUnited States
CollaboratorsNational Institute on Deafness and Other Communication Disorders (NIDCD)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 3, 2019
Enrollment StartFeb 1, 2020
Primary CompletionJul 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.1 years ago

Interventions

No Intervention Providedother

No Intervention Provided